Objective To develop and validate a 10-year predictive model for cardiovascular and metabolic disease (CVMD) risk using ...
The next major challenge for artificial intelligence in drug development lies in proving its value in real-world settings. A new technology not only supports the generation of novel chemical entities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback